USE OF C1QTNF5

PROBLEM TO BE SOLVED: To obtain a diagnostic marker for arteriosclerotic diseases and a prophylactic and a therapeutic agent against arteriosclerotic diseases. SOLUTION: The prophylactic and the therapeutic agent against arteriosclerotic diseases comprises a compound or its salt for modulating prote...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SHIBATA SACHIO, FUSE HIROMITSU
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PROBLEM TO BE SOLVED: To obtain a diagnostic marker for arteriosclerotic diseases and a prophylactic and a therapeutic agent against arteriosclerotic diseases. SOLUTION: The prophylactic and the therapeutic agent against arteriosclerotic diseases comprises a compound or its salt for modulating protein having the same or substantially the same amino acid sequence as that of C1QTNF5, its partial peptide or its salt. COPYRIGHT: (C)2005,JPO&NCIPI